Matthew Dyer
Impact in
-
- Cardiac Health and Mental Health
- Heart Failure Treatment and Management
- Biochemistry top 10%
- Blood transfusion and management
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 9
- Pharmaceutical Economics and Policy 3
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Linda Sharples (7 shared papers)Martin Buxton (7 shared papers)Kimberley Goldsmith (3 shared papers)Jeni Warburton (1 shared paper)Ann Strydom (1 shared paper)Nazneen Rahman (1 shared paper)Samer A.M. Nashef (1 shared paper)Peter M. Schofield (1 shared paper)
- Journals
- Health and Quality of Life Outcomes (4 papers)BMJ Open (2 papers)The Journal of Heart and Lung Transplantation (2 papers)The Lancet Oncology (2 papers)Value in Health (2 papers)
- Partner nations
- United KingdomCanadaAustralia
In The Last Decade
Matthew Dyer
22 papers receiving 751 citations
Peers
Comparison fields: 5 of 94
- Cardiology and Cardiovascular Medicine 268
- Biochemistry 51
- Economics and Econometrics 223
- Critical Care and Intensive Care Medicine 36
- Geriatrics and Gerontology 24
Countries citing papers authored by Matthew Dyer
This map shows the geographic impact of Matthew Dyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Dyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Dyer more than expected).
Fields of papers citing papers by Matthew Dyer
This network shows the impact of papers produced by Matthew Dyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Dyer. The network helps show where Matthew Dyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Dyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 326 | |
| 2 | 2008 | 55 | |
| 3 | 2017 | 53 | |
| 4 | 2006 | 41 | |
| 5 | 2009 | 40 | |
| 6 | 2010 | 39 | |
| 7 | 2014 | 36 | |
| 8 | 2017 | 31 | |
| 9 | 2012 | 27 | |
| 10 | 2004 | 24 | |
| 11 | 2008 | 13 | |
| 12 | 2020 | 13 | |
| 13 | 2007 | 12 | |
| 14 | 2006 | 11 | |
| 15 | 2019 | 10 | |
| 16 | 2011 | 10 | |
| 17 | 2012 | 9 | |
| 18 | 2013 | 8 | |
| 19 | 2009 | 6 | |
| 20 | 2022 | 3 |
About Matthew Dyer
Matthew Dyer is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine, Surgery, Reproductive Medicine and General Health Professions, having authored 22 papers that have together received 769 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Ovarian cancer diagnosis and treatment (4 papers), BRCA gene mutations in cancer (3 papers), Lung Cancer Treatments and Mutations (3 papers), Pharmaceutical Economics and Policy (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cardiac Structural Anomalies and Repair (2 papers) and Global Health Care Issues (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (268 citations), Biochemistry (51 citations), Economics and Econometrics (223 citations), Critical Care and Intensive Care Medicine (36 citations) and Geriatrics and Gerontology (24 citations). Matthew Dyer has collaborated with scholars based in United Kingdom, Canada and Australia. Frequent co-authors include Linda Sharples, Martin Buxton, Kimberley Goldsmith, Jeni Warburton, Ann Strydom, Nazneen Rahman, Samer A.M. Nashef, Peter M. Schofield, A. A. Klein and Johanna Armstrong. Their work appears in journals such as Health and Quality of Life Outcomes, BMJ Open, The Journal of Heart and Lung Transplantation, The Lancet Oncology and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.